DK1583538T3 - Anvendelse af 3-methozy-pregnenolon til fremstilling af et lægemiddel til behandling af neurodegenerative sygdomme - Google Patents
Anvendelse af 3-methozy-pregnenolon til fremstilling af et lægemiddel til behandling af neurodegenerative sygdommeInfo
- Publication number
- DK1583538T3 DK1583538T3 DK04702722T DK04702722T DK1583538T3 DK 1583538 T3 DK1583538 T3 DK 1583538T3 DK 04702722 T DK04702722 T DK 04702722T DK 04702722 T DK04702722 T DK 04702722T DK 1583538 T3 DK1583538 T3 DK 1583538T3
- Authority
- DK
- Denmark
- Prior art keywords
- alpha
- pregnenolone
- medicament
- methozy
- manufacture
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Physiology (AREA)
- Otolaryngology (AREA)
- Nutrition Science (AREA)
- Dermatology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0300507A FR2850023B1 (fr) | 2003-01-17 | 2003-01-17 | Medicaments pour le systeme nerveux |
PCT/FR2004/000086 WO2004067010A1 (fr) | 2003-01-17 | 2004-01-16 | Utilisation de la 3-methoxy-pregnenolone pour la preparation d’un medicament destine a traiter les maladies neurodegeneratives |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1583538T3 true DK1583538T3 (da) | 2008-12-01 |
Family
ID=32605831
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK04702722T DK1583538T3 (da) | 2003-01-17 | 2004-01-16 | Anvendelse af 3-methozy-pregnenolon til fremstilling af et lægemiddel til behandling af neurodegenerative sygdomme |
Country Status (9)
Country | Link |
---|---|
US (3) | US8034798B2 (de) |
EP (1) | EP1583538B1 (de) |
AT (1) | ATE402710T1 (de) |
DE (1) | DE602004015406D1 (de) |
DK (1) | DK1583538T3 (de) |
ES (1) | ES2311790T3 (de) |
FR (1) | FR2850023B1 (de) |
PT (1) | PT1583538E (de) |
WO (1) | WO2004067010A1 (de) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2850023B1 (fr) * | 2003-01-17 | 2007-04-06 | Mapreg | Medicaments pour le systeme nerveux |
WO2008109719A2 (en) * | 2007-03-07 | 2008-09-12 | Janssen Pharmaceutica N.V. | Steroids derivatives as selective progesterone receptor modulators |
CN103764151B (zh) * | 2011-05-20 | 2017-05-17 | 国家医疗保健研究所 | Cb1受体拮抗剂 |
ES2951664T3 (es) * | 2011-09-08 | 2023-10-24 | Sage Therapeutics Inc | Esteroides neuroactivos, composiciones y usos de los mismos |
US10259839B2 (en) * | 2012-11-28 | 2019-04-16 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | 3-(4′-substituted)-benzyl-ether derivatives of pregnenolone |
EP3932932A1 (de) | 2013-03-13 | 2022-01-05 | Sage Therapeutics, Inc. | Neuroaktive steroide und verfahren zur verwendung davon |
EP4306114A1 (de) | 2014-06-18 | 2024-01-17 | Sage Therapeutics, Inc. | Oxysterole und verfahren zu ihrer verwendung |
MA42409A (fr) | 2015-07-06 | 2018-05-16 | Sage Therapeutics Inc | Oxystérols et leurs procédés d'utilisation |
RU2021100620A (ru) | 2015-07-06 | 2021-01-29 | Сейдж Терапьютикс, Инк. | Оксистеролы и способы их применения |
MY197698A (en) | 2015-07-06 | 2023-07-06 | Sage Therapeutics Inc | Oxysterols and methods of use thereof |
EP3165225A1 (de) | 2015-11-06 | 2017-05-10 | Mapreg | Nicht biologisch umsetzbare c3-substitutierte pregnenolonderivate zur behandlung von drogenmissbrauch |
US9943528B2 (en) | 2016-03-01 | 2018-04-17 | Mapreg | Non-bioconvertible C3-substituted pregnenolone derivatives for use in the treatment of treatment-resistant depression |
WO2017149339A1 (en) | 2016-03-01 | 2017-09-08 | Mapreg | Non-bioconvertible c3-substituted pregnenolone derivatives for use in the treatment of treatment-resistant depression |
LT3436022T (lt) | 2016-04-01 | 2022-06-27 | Sage Therapeutics, Inc. | Oksisteroliai ir jų panaudojimo būdai |
WO2017193046A1 (en) | 2016-05-06 | 2017-11-09 | Sage Therapeutics, Inc. | Oxysterols and methods of use thereof |
ES2884071T3 (es) | 2016-07-07 | 2021-12-10 | Sage Therapeutics Inc | 24-hidroxiesteroles sustituidos en 11 para el tratamiento de afecciones relacionadas con NMDA |
CN110023323A (zh) | 2016-09-30 | 2019-07-16 | 萨奇治疗股份有限公司 | C7取代的氧固醇及其作为nmda调节剂的方法 |
CA3041088C (en) | 2016-10-18 | 2024-05-21 | Sage Therapeutics, Inc. | Oxysterols and methods of use thereof |
MA46565A (fr) | 2016-10-18 | 2019-08-28 | Sage Therapeutics Inc | Oxystérols et leurs procédés d'utilisation |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5563131A (en) * | 1994-08-04 | 1996-10-08 | Pherin Corporation | Pregnane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods |
JP4313435B2 (ja) * | 1995-07-24 | 2009-08-12 | トラスティーズ オブ ボストン ユニバーシティー | プレグネノロンサルフェート誘導体によるnmdaレセプター活性の抑制 |
US6245757B1 (en) * | 1997-10-03 | 2001-06-12 | Research Corporation Technologies, Inc. | Use of progestins to treat ischemic event |
FR2806303B1 (fr) * | 2000-03-17 | 2002-09-27 | Inst Nat Sante Rech Med | Composes capables de se lier a des proteines constituantes ou associees aux elements du cytosquelette et leurs applications pour la fabrication de medicaments |
US20020072509A1 (en) * | 2000-10-11 | 2002-06-13 | Stein Donald Gerald | Methods for the treatment of a traumatic central nervous system injury |
WO2002036128A1 (en) * | 2000-11-06 | 2002-05-10 | Trustees Of Boston University | Neuroactive steroid derivatives and methods of use |
EP1310258A1 (de) * | 2001-11-08 | 2003-05-14 | Etienne-Emile Baulieu | Steroid-Enantiomere zur Erhöhung des Erinnerungsvermögens und der kognitiven Funktion |
FR2850023B1 (fr) * | 2003-01-17 | 2007-04-06 | Mapreg | Medicaments pour le systeme nerveux |
US9339508B2 (en) * | 2003-01-17 | 2016-05-17 | Mapreg | Use of 3-methoxy-pregnenolone for the preparation of a drug for treating a traumatic brain injury |
-
2003
- 2003-01-17 FR FR0300507A patent/FR2850023B1/fr not_active Expired - Lifetime
-
2004
- 2004-01-16 DE DE602004015406T patent/DE602004015406D1/de not_active Expired - Lifetime
- 2004-01-16 ES ES04702722T patent/ES2311790T3/es not_active Expired - Lifetime
- 2004-01-16 AT AT04702722T patent/ATE402710T1/de active
- 2004-01-16 WO PCT/FR2004/000086 patent/WO2004067010A1/fr active IP Right Grant
- 2004-01-16 US US10/542,495 patent/US8034798B2/en active Active
- 2004-01-16 DK DK04702722T patent/DK1583538T3/da active
- 2004-01-16 PT PT04702722T patent/PT1583538E/pt unknown
- 2004-01-16 EP EP04702722A patent/EP1583538B1/de not_active Expired - Lifetime
-
2008
- 2008-09-26 US US12/232,993 patent/US8334278B2/en active Active
-
2015
- 2015-11-24 US US14/950,178 patent/US10561671B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
ATE402710T1 (de) | 2008-08-15 |
US20060199790A1 (en) | 2006-09-07 |
EP1583538A1 (de) | 2005-10-12 |
US8334278B2 (en) | 2012-12-18 |
DE602004015406D1 (de) | 2008-09-11 |
WO2004067010A1 (fr) | 2004-08-12 |
FR2850023B1 (fr) | 2007-04-06 |
US8034798B2 (en) | 2011-10-11 |
ES2311790T3 (es) | 2009-02-16 |
PT1583538E (pt) | 2008-10-30 |
US20090143347A1 (en) | 2009-06-04 |
US20160166586A1 (en) | 2016-06-16 |
FR2850023A1 (fr) | 2004-07-23 |
EP1583538B1 (de) | 2008-07-30 |
US10561671B2 (en) | 2020-02-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1583538T3 (da) | Anvendelse af 3-methozy-pregnenolon til fremstilling af et lægemiddel til behandling af neurodegenerative sygdomme | |
UA85708C2 (ru) | Лекарственные комбинации, содержащие бензоксазины, для лечения заболеваний дыхательных путей | |
GEP20053595B (en) | Cyclopentanoindoles, Compositions Containing Such Compounds and Methods of Treatment | |
BRPI0720551A2 (pt) | composto ou um sal farmaceuticamente aceitável do mesmo, e, uso do mesmo, método para o tratamento de câncer, processos para a preparação de uma composição farmacêutica e de um composto ou de um sal farmaceuticamente aceitável do mesmo | |
NO20092723L (no) | Indazolylester og amidderivater for behandling av gluccocorticoid reseptormedierte sykdommer | |
ATE339406T1 (de) | Chinazoline verbindungen als heilmittel | |
NO20070576L (no) | Nye hydantionderivater for behandling av obstruktive luftveissykdommer. | |
PT1326613E (pt) | Utilizacao de derivados de imidazo[1,2-a]piridin-,imidazo[1,2-a]pirimidin- e imidazo[1,2-a]pirazin-3-il-amina substituidos para a fabricacao de medicamentos para inibicao de nos | |
HK1062677A1 (en) | 17Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | |
WO2005075425A3 (en) | Substituted bisarylurea derivatives as kinase inhibitors | |
IS8230A (is) | Setið 2-amínótetralín til notkunar við meðferð á þunglyndi | |
ATE442142T1 (de) | Fredericamycin-derivate als arzneimittel zur tumorbehandlung | |
DE60315492D1 (de) | Medizinisch verwendbare arylethanolamin verbindungen | |
NO20091938L (no) | 7,8-dihydro-1,6-naftyridin-5(6H)-oner og relaterte bicykliske forbindelser som inhibitorer av dipeptidyl-peptidaser IV og metoder | |
BR0315580A (pt) | Derivados de metileno uréia | |
SG148177A1 (en) | Novel cis-imidazolines | |
CY1109045T1 (el) | Ρετινοειδη για τη θεραπεια του εμφυσηματος | |
WO2005037798A3 (en) | Amide or thiomide derivatives and their use in the treatment of pain | |
UA90504C2 (ru) | Лекарственное средство для лечения заболеваний дыхательных путей | |
MXPA05010020A (es) | Derivados de oxamida. | |
MXPA05005790A (es) | Aminoalcoxiindoles como ligandos del receptor 5-ht6 para el tratamiento de enfermedades del sistema nervioso central. | |
DE60215313D1 (de) | Indolderivate und deren verwendung als gnrh antagonisten | |
DK1511496T3 (da) | Fremgangsmåde til behandling eller forebyggelse af immunmedierede sygdomme og farmaceutisk præparat til anvendelse heri | |
EA200870223A1 (ru) | Производные бензоизоиндола для лечения боли | |
AU2001246999A1 (en) | New neurokinin antagonists for use as medicaments |